Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas

Clinical Endocrinology

Volumn 67, Issue 3, 2007, Pages 370-376

  Haven, C J ^b   Van Puijenbroek, M ^b   Tan, M H ^c   Teh, B T ^c   Fleuren, G J ^b   Van Wezel, T ^b   Morreau, H ^a,b  

^a Leiden University Medical Centre ^*  (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; PARAFFIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; FRAMESHIFT MUTATION; GENE SEQUENCE; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG METASTASIS; LYMPH NODE; MALE; MISSENSE MUTATION; MULTIPLE ENDOCRINE NEOPLASIA; PARATHYROID CARCINOMA; PRIORITY JOURNAL; SOMATIC MUTATION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL SPECIMEN BANKS; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; FRAMESHIFT MUTATION; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; MUTATION, MISSENSE; NETHERLANDS; PARAFFIN EMBEDDING; PARATHYROID NEOPLASMS; PROTO-ONCOGENE PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 34548034205     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02894.x     Document Type: Article

References (28)

1. Adami, S., Marcocci, C. Gatti, D. (2002) Epidemiology of primary hyperparathyroidism in Europe. Journal of Bone and Mineral Research, 17 (Suppl. 2 N18 N23.
2. Marx, S.J. (2000) Hyperparathyroid and hypoparathyroid disorders. New England Journal of Medicine, 343, 1863 1875.
3. Thakker, R.V. (2004) Genetics of endocrine and metabolic disorders: parathyroid. Reviews in Endocrine and Metabolic Disorders, 5, 37 51.
4. Dwight, T., Twigg, S., Delbridge, L., Wong, F.K., Farnebo, F., Richardson, A.L., Nelson, A., Zedenius, J., Philips, J., Larsson, C., Teh, B.T. Robinson, B. (2000) Loss of heterozygosity in sporadic parathyroid tumours: involvement of chromosome 1 and the MEN1 gene locus in 11q13. Clinical Endocrinology, 53, 85 92.
5. Heppner, C., Kester, M.B., Agarwal, S.K., Debelenko, L.V., Emmert-Buck, M.R., Guru, S.C., Manickam, P., Olufemi, S.E., Skarulis, M.C., Doppman, J.L., Alexander, R.H., Kim, Y.S., Saggar, S.K., Lubensky, I.A., Zhuang, Z., Liotta, L.A., Chandrasekharappa, S.C., Collins, F.S., Spiegel, A.M., Burns, A.L. Marx, S.J. (1997) Somatic mutation of the MEN1 gene in parathyroid tumours. Nature Genetics, 16, 375 378.
6. Miedlich, S., Krohn, K., Lamesch, P., Muller, A. Paschke, R. (2000) Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism. European Journal of Endocrinology, 143, 47 54.
7. Agarwal, S.K., Schrock, E., Kester, M.B., Burns, A.L., Heffess, C.S., Ried, T. Marx, S.J. (1998) Comparative genomic hybridization analysis of human parathyroid tumors. Cancer Genetics and Cytogenetics, 106, 30 36.
8. Kytola, S., Farnebo, F., Obara, T., Isola, J., Grimelius, L., Farnebo, L.O., Sandelin, K. Larsson, C. (2000) Patterns of chromosomal imbalances in parathyroid carcinomas. American Journal of Pathology, 157, 579 586.
9. Brandi, M.L., Marx, S.J., Aurbach, G.D. Fitzpatrick, L.A. (1987) Familial multiple endocrine neoplasia type I: a new look at pathophysiology. Endocrine Reviews, 8, 391 405.
10. Dionisi, S., Minisola, S., Pepe, J., De Geronimo, S., Paglia, F., Memeo, L. Fitzpatrick, L.A. (2002) Concurrent parathyroid adenomas and carcinoma in the setting of multiple endocrine neoplasia type 1: presentation as hypercalcemic crisis. Mayo Clinic Proceedings, 77, 866 869.
11. Sato, M., Miyauchi, A., Namihira, H., Bhuiyan, M.M., Imachi, H., Murao, K. Takahara, J. (2000) A newly recognized germline mutation of MEN1 gene identified in a patient with parathyroid adenoma and carcinoma. Endocrine, 12, 223 226.
12. Cetani, F., Pardi, E., Borsari, S., Viacava, P., Dipollina, G., Cianferotti, L., Ambrogini, E., Gazzerro, E., Colussi, G., Berti, P., Miccoli, P., Pinchera, A. Marcocci, C. (2004) Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. Journal of Clinical Endocrinology and Metabolism, 89, 5583 5591.
13. Shane, E. (2001) Clinical review 122: parathyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 86, 485 493.
14. Haven, C.J., van Puijenbroek, M., Karperien, M., Fleuren, G.J. Morreau, H. (2004) Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and 11q in parathyroid carcinoma. Journal of Pathology, 202, 86 94.
15. Shattuck, T.M., Valimaki, S., Obara, T., Gaz, R.D., Clark, O.H., Shoback, D., Wierman, M.E., Tojo, K., Robbins, C.M., Carpten, J.D., Farnebo, L.O., Larsson, C. Arnold, A. (2003) Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. New England Journal of Medicine, 349, 1722 1729.
16. Bradley, K.J., Cavaco, B.M., Bowl, M.R., Harding, B., Cranston, T., Fratter, C., Besser, G.M., Conceicao, P.M., Davie, M.W., Dudley, N., Leite, V., Sadler, G.P., Seller, A. Thakker, R.V. (2006) Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours. Clinical Endocrinology, 64, 299 306.
17. Carpten, J.D., Robbins, C.M., Villablanca, A., Forsberg, L., Presciuttini, S., Bailey-Wilson, J., Simonds, W.F., Gillanders, E.M., Kennedy, A.M., Chen, J.D., Agarwal, S.K., Sood, R., Jones, M.P., Moses, T.Y., Haven, C., Petillo, D., Leotlela, P.D., Harding, B., Cameron, D., Pannett, A.A., Hoog, A., Heath, H. III., James-Newton, L.A., Robinson, B., Zarbo, R.J., Cavaco, B.M., Wassif, W., Perrier, N.D., Rosen, I.B., Kristoffersson, U., Turnpenny, P.D., Farnebo, L.O., Besser, G.M., Jackson, C.E., Morreau, H., Trent, J.M., Thakker, R.V., Marx, S.J., Teh, B.T., Larsson, C. Hobbs, M.R. (2002) HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nature Genetics, 32, 676 680.
18. Howell, V.M., Haven, C.J., Kahnoski, K., Khoo, S.K., Petillo, D., Chen, J., Fleuren, G.J., Robinson, B.G., Delbridge, L.W., Philips, J., Nelson, A.E., Krause, U., Hammje, K., Dralle, H., Hoang-Vu, C., Gimm, O., Marsh, D.J., Morreau, H. Teh, B.T. (2003) HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. Journal of Medical Genetics, 40, 657 663.
19. Krebs, L.J., Shattuck, T.M. Arnold, A. (2005) HRPT2 mutational analysis of typical sporadic parathyroid adenomas. Journal of Clinical Endocrinology and Metabolism, 90, 5015 5017.
20. Marx, S.J., Simonds, W.F., Agarwal, S.K., Burns, A.L., Weinstein, L.S., Cochran, C., Skarulis, M.C., Spiegel, A.M., Libutti, S.K., Alexander, H.R. Jr., Chen, C.C., Chang, R., Chandrasekharappa, S.C. Collins, F.S. (2002) Hyperparathyroidism in hereditary syndromes: special expressions and special managements. Journal of Bone and Mineral Research, 17 (Suppl. 2 N37 N43.
21. Cetani, F., Pardi, E., Ambrogini, E., Lemmi, M., Borsari, S., Cianferotti, L., Vignali, E., Viacava, P., Berti, P., Mariotti, S., Pinchera, A. Marcocci, C. (2006) Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management. Clinical Endocrinology, 64, 146 152.
22. Mizusawa, N., Uchino, S., Iwata, T., Tsuyuguchi, M., Suzuki, Y., Mizukoshi, T., Yamashita, Y., Sakurai, A., Suzuki, S., Beniko, M., Tahara, H., Fujisawa, M., Kamata, N., Fujisawa, K., Yashiro, T., Nagao, D., Golam, H.M., Sano, T., Noguchi, S. Yoshimoto, K. (2006) Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome. Clinical Endocrinology, 65, 9 16.
23. Haven, C.J., Howell, V.M., Eilers, P.H., Dunne, R., Takahashi, M., van Puijenbroek, M., Furge, K., Kievit, J., Tan, M.H., Fleuren, G.J., Robinson, B.G., Delbridge, L.W., Philips, J., Nelson, A.E., Krause, U., Dralle, H., Hoang-Vu, C., Gimm, O., Morreau, H., Marsh, D.J. Teh, B.T. (2004) Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype. Cancer Research, 64, 7405 7411.
24. Tan, M.H., Morrison, C., Wang, P., Yang, X., Haven, C.J., Zhang, C., Zhao, P., Tretiakova, M.S., Korpi-Hyovalti, E., Burgess, J.R., Soo, K.C., Cheah, W.K., Cao, B., Resau, J., Morreau, H. Teh, B.T. (2004) Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clinical Cancer Research, 10, 6629 6637.
25. van Puijenbroek, M., Dierssen, J.W., Stanssens, P., van Eijk, R., Cleton-Jansen, A.M., van Wezel, T. Morreau, H. (2005) Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the Mass EXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancer. Journal of Molecular Diagnostics, 7, 623 630.
26. Rubin, M.R. Silverberg, S.J. (2005) Editorial: HRPT2 in parathyroid cancer: a piece of the puzzle. Journal of Clinical Endocrinology and Metabolism, 90, 5505 5507.
27. Sieben, N.L., ter Haar, N.T., Cornelisse, C.J., Fleuren, G.J. Cleton-Jansen, A.M. (2000) PCR artifacts in LOH and MSI analysis of microdissected tumor cells. Human Pathology, 31, 1414 1419.
28. Gill, A.J., Clarkson, A., Gimm, O., Keil, J., Dralle, H., Howell, V.M. Marsh, D.J. (2006) Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias. American Journal of Surgery Pathology, 30, 1140 1149.